The Antitrust Week in Review

Here are some of the developments in antitrust news this past week that we found interesting and are following.

China Vitamin C Price-Fixing Verdict Scrutinized by Court.  Federal courts often find the extent to which U.S. antitrust laws have a global reach to be one of the thorniest issues to deal with.  The U.S. Court of Appeals for the Second Circuit is wrestling with this issue as it reviews a $147.8 million jury verdict against two Chinese vitamin C makers.

Albertsons and Safeway agree to divest 168 stores to win antitrust approval for merger.   Two top supermarket chains are having a special sale – 168 stores – in order to win FTC approval of their $9.2 billion merger.

FTC Puts Conditions on Sun Pharmaceutical’s Proposed Acquisition of Ranbaxy.  Pharmaceutical companies Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd. have agreed to divest Ranbaxy’s interests in generic minocycline tablets  in order to settle FTC charges that Sun’s $4 billion proposed acquisition of Ranbaxy would be anticompetitive.  Completion of the deal would create the world’s fifth-largest  (and India’s largest) drug maker.

Tagged in: Antitrust Litigation,